Changing color of antiepileptic pills raises risk of patients’ non-adherence, study shows

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f19 (Published 3 January 2013)
Cite this as: BMJ 2013;346:f19

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Susan Mayor
  1. 1London

Changing the color of antiepileptic tablets is associated with an increased risk of patients with seizure disorder stopping taking them as prescribed, a US study has found.1

Researchers analyzed a national database of prescription records of patients with health insurance who started taking an antiepileptic drug between 2001 and 2006. They identified 11 472 patients as being “non-persistent,” defined as failing to fill a prescription within five days of the date required to take the drug as prescribed.

They assessed changes in pill color and shape of generic drugs dispensed in the two refills before patients became non-persistent and compared them with 50 050 controls who had no …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL